Centogene: Mary Sheahan, Berndt Modig
Mary Sheahan has been appointed to the supervisory board of German rare disease company Centogene, pending her confirmation at the company's next general shareholder meeting. As of Dec. 1, she will serve as an interim member of the board. She is also scheduled to become chair of the audit committee. Sheahan is currently CFO of Avillion.
Berndt Modig will step down from Centogene's supervisory board at the next general shareholder meeting. He has been a member of the board since 2018.